This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient — an area of health care that has become increasingly complex. Recent advances in drug therapy for adult ICU patients (including evolving and controversial data) will be reviewed and assessed in terms of clinical, humanistic, and economic outcomes. Direct questions or comments to Gil Fraser, PharmD, at fraseg@mmc.org.
Get full access to this article
View all access options for this article.
References
1.
CoursinD.B., WoodK.E.Corticosteroid supplementation for adrenal insufficiency.JAMA.2002; 287: 236–40.
2.
MacLarenR., JungR.Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults.Pharmacotherapy.2002; 22: 1140–56.
FesslerM.B., O'BrienJ.M., DouglasI.S.Laboratory predictors of relative adrenal insufficiency in septic shock.Crit Care Med.2003; 31: 2251–2.
5.
DorinR.I., QualisC.R., CrapoL.M.Diagnosis of adrenal insufficiency.Ann Intern Med.2003; 139: 194–204.
6.
ZalogaG., MarikP.Diagnosis and treatment of adrenal insufficiency during septic shock.Crit Care Med.2003; 2252–3.
7.
MarikP.E., ZalogaG.P.The central nervous system hypothalamic-pituitary-adrenal axis in sepsis.Crit Care Med.2002; 30: 490–1.
8.
MarikP.E., ZalogaG.P.Adrenal insufficiency during septic shock.Crit Care Med.2003; 31: 141–5.
9.
MarikP.E., ZalogaG.P.Adrenal insufficiency in the critically ill.Chest.2002; 122: 1784–96.
10.
LedinghamI.M., WattI.Influence of sedation on mortality in critically ill multiple trauma patients.Lancet.1983; 1: 1270
11.
SlotmanG.J., FisherC.J., BoneR.C.Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock.Crit Care Med.1993; 21: 191–5.
12.
LeferingR., NeugebauerE.A.Steroid controversy in sepsis and septic shock: A meta-analysis.Crit Care Med.1995; 23: 1294–1303.
13.
BollaertP.E., ChapentierC., LevyB.Reversal of late septic shock with supraphysiologic doses of hydrocortisone.Crit Care Med.1998; 26: 645–50.
14.
BriegelJ., ForstH., HallerM.Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double blind, single center study.Crit Care Med.1998; 27: 723–32.
15.
AnnaneD., SebilleV., CharpentierC.Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.JAMA.2002; 288: 862–71.
Brun-BuissonC., BrochardL.Corticosteroid therapy in acute respiratory distress syndrome.JAMA.1998; 280: 182–3.
19.
BernardG.R., LuceJ.M., SprungC.L.High-dose corticosteroids in patients with the adult respiratory distress syndrome.N Engl J Med.1987; 317: 1565–70.
20.
LuceJ.M., MontgomeryA.B., MarksJ.D.Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock.Am Rev Respir Dis.1988; 138: 62–8.
21.
MeduriG.U., HeadleyS., GoldenE.Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome.JAMA.1998; 280: 159–65.
22.
AnnaneD., SebilleV., BellissantE.Corticosteroids for patients with septic shock.JAMA.2003; 289: 43–4.
